Ranirestat
CAS: 147254-64-6
Ref. 3D-FR103275
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Product Information
- (3R)-2'-(4-bromo-2-fluorobenzyl)-1'H,2H,5H-spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetrone
- (3R)-2′-(4-Bromo-2-fluorobenzyl)-1′,2′,3′,4′-tetrahydrospiro[pyrrolidine-3,4′-pyrrolo[1,2-a]pyrazine]-1′,2,3′,5-tetraone
- (3R)-2′-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4′-1′H-pyrrolo[1,2-a]pyrazine]-1′,2,3′,5(2′H)-tetraone
- (3R)-2′-[(4-Bromo-2-fluorophenyl)methyl]spiro[pyrrolidine-3,4′(1′H)-pyrrolo[1,2-a]pyrazine]-1′,2,3′,5(2′H)-tetrone
- As-3201
- SX-3030(racemate)
- SX-3202((+)-(S)-isomer)
- Spiro[pyrrolidine-3,4′(1′H)-pyrrolo[1,2-a]pyrazine]-1′,2,3′,5(2′H)-tetrone, 2′-[(4-bromo-2-fluorophenyl)methyl]-, (-)-
- Spiro[pyrrolidine-3,4′(1′H)-pyrrolo[1,2-a]pyrazine]-1′,2,3′,5(2′H)-tetrone, 2′-[(4-bromo-2-fluorophenyl)methyl]-, (3R)-
- Sx-3201
- See more synonyms
Ranirestat is a fatty acid that is used as a pharmaceutical agent. It is known to be biocompatible and has been shown to have hepatic impairment properties. Ranirestat inhibits DPP-IV, which is an enzyme that degrades the incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It has been shown to be effective in treating diabetic patients who are not on any other medications or treatments. Ranirestat has also been shown to prevent or reduce the severity of diabetic neuropathy in animal models. This drug may provide an alternative treatment for diabetes mellitus type 2 by promoting the release of GLP-1 and GIP from intestinal cells, thereby reducing hyperglycemia and improving insulin sensitivity.
Chemical properties
Technical inquiry about: 3D-FR103275 Ranirestat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.